Jenny Seligmann

11PUBLICATIONS
94CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 06, 2026
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design.

Naureen Starling, Elena Elez, John H Strickler

|May 01, 2025
Targeting the MAP Kinase Pathway in Colorectal Cancer: A Journey in Personalized Medicine.

Jordan W Appleyard, Christopher J M Williams, Paolo Manca

|Jul 31, 2024
Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.

Christopher J M Williams, Richard Gray, Robert K Hills

|Jun 26, 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer.

Christopher J M Williams, Faye Elliott, Nancy Sapanara

|Jan 30, 2023
Personalizing neoadjuvant chemotherapy for locally advanced colon cancer: protocols for the international phase III FOxTROT2 and FOxTROT3 randomized controlled trials.

James R Platt, Christopher J M Williams, Zoe Craig

|Jan 19, 2023
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial.

Dion Morton, Matthew Seymour, Laura Magill

Pageof 2